Literature DB >> 17328838

Isolation and characterization of human CXCR4-positive pancreatic cells.

T Koblas1, K Zacharovová, Z Berková, M Mindlová, P Girman, E Dovolilová, L Karasová, F Saudek.   

Abstract

The existence of an adult PSC that may be used in the treatment of diabetes is still a matter of scientific debate as conclusive evidence of such a stem cell in the adult pancreas has not yet been presented. The main reason why putative PSC has not yet been identified is the lack of specific markers that may be used to isolate and purify them. In order to increase the list of potential PSC markers we have focused on the human pancreatic cells that express cell surface receptor CXCR4, a marker of stem cells derived from different adult tissues. Here we report that CXCR4-positive pancreatic cells express markers of pancreatic endocrine progenitors (neurogenin-3, nestin) and markers of pluripotent stem cells (Oct-4, Nanog, ABCG2, CD133, CD117). Upon in vitro differentiation, these cells form ILCC and produce key islet hormones including insulin. Based on our results, we assume that CXCR4 marks pancreatic endocrine progenitors and in combination with other cell surface markers may be used in the attempt to identify and isolate PSC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328838

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  9 in total

Review 1.  Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.

Authors:  M Mimeault; S K Batra
Journal:  Gut       Date:  2008-10       Impact factor: 23.059

Review 2.  Somatic cell dedifferentiation/reprogramming for regenerative medicine.

Authors:  Thiyagarajan Ramesh; Sun-Hee Lee; Choon-Soo Lee; Yoo-Wook Kwon; Hyun-Jai Cho
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 3.  The cancer stem cell niche--there goes the neighborhood?

Authors:  Stephanie M Cabarcas; Lesley A Mathews; William L Farrar
Journal:  Int J Cancer       Date:  2011-09-14       Impact factor: 7.396

Review 4.  Virology of SARS-CoV-2 and management of nCOVID-19 utilizing immunomodulation properties of human mesenchymal stem cells-a literature review.

Authors:  Kunj Sachdeva; Anil Kumar; Sujata Mohanty
Journal:  Stem Cell Investig       Date:  2021-11-10

Review 5.  Epigenetic gene regulation in stem cells and correlation to cancer.

Authors:  Lesley A Mathews; Francesco Crea; W L Farrar
Journal:  Differentiation       Date:  2009-05-14       Impact factor: 3.880

Review 6.  Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

7.  Migration path of stem cells involved in the repair of damaged pancreatic tissue caused by pancreatitis.

Authors:  Jiaqing Gong; Yonghua Wang; Yongkuan Cao
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Promotion of beta-cell differentiation in pancreatic precursor cells by adult islet cells.

Authors:  Wei Chen; Salma Begum; Lynn Opare-Addo; Justin Garyu; Thomas F Gibson; Alfred L M Bothwell; Virginia E Papaioannou; Kevan C Herold
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

9.  Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.

Authors:  Stéphane Cauchi; David Meyre; Emmanuelle Durand; Christine Proença; Michel Marre; Samy Hadjadj; Hélène Choquet; Franck De Graeve; Stefan Gaget; Frederic Allegaert; Jérôme Delplanque; Marshall Alan Permutt; Jon Wasson; Ilana Blech; Guillaume Charpentier; Beverley Balkau; Anne-Claire Vergnaud; Sébastien Czernichow; Wolfgang Patsch; Mohamed Chikri; Benjamin Glaser; Robert Sladek; Philippe Froguel
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.